Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;41(6):1779-1784.
doi: 10.1007/s10067-022-06186-z. Epub 2022 Apr 30.

Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain

Clara Udaondo  1   2   3 , Claudia Millán-Longo  4 , Celia Permuy  5 , Laura Valladares  5 , Iker Falces-Romero  6 , Celia Muñoz-Gómez  4 , Mónica Morales-Higuera  4 , Rosa Alcobendas  4 , Agustín Remesal  4 , Sara Murias  4 , Cristina Calvo  7   8   5
Affiliations

Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain

Clara Udaondo et al. Clin Rheumatol. 2022 Jun.

Abstract

SARS-CoV-2 infections in children are frequently asymptomatic or mild and can go unnoticed. This study aimed to describe the seroprevalence and clinical course of SARS-CoV-2 in a cohort of children with rheumatic diseases in a real-life setting and assess possible risk factors. A cross-sectional study was performed in a paediatric rheumatology unit (September 2020 to February 2021). At inclusion, a specific questionnaire was completed and SARS-CoV-2 serology was performed. Demographics, treatment and disease activity of patients with and without laboratory-confirmed SARS-CoV-2 infection were compared. A total of 105 children were included. SARS-CoV-2 infection was demonstrated in 27 patients (25.7%). The mean age was 11.8 years, and most patients were females (72.4%). The most frequent underlying condition was juvenile idiopathic arthritis (70.3%; 19/27). Patients received immunosuppressive treatment in 78% of cases (21/27). Overall, 44.4% (12/27) of infected patients were asymptomatic. A total of 66.7% (18/27) of patients did not require medical assistance. Three patients required hospital admission because of COVID-19. Children with confirmed SARS-CoV-2 infection were less frequently in remission (52% vs 72%; p 0.014). Moderate disease activity and treatment with oral corticosteroids were associated with higher risk for SARS-CoV-2 (OR 5.05; CI 95%: 1.56-16.3 and OR 4.2; CI 95%: 1.26-13.9, respectively). In a cohort of Spanish paediatric patients with rheumatic diseases, clinical course of COVID-19 was mild, with more than one third of asymptomatic cases. Higher disease activity and oral corticosteroids appear to be risk factors for SARS-CoV-2 infection. Key Points • We aimed to investigate the seroprevalence of SARS-CoV-2 infection in a cohort of Spanish paediatric patients with RD, testing both symptomatic and asymptomatic patients. We also compared treatment and disease activity of patients with and without laboratory-confirmed SARS-CoV-2 infection. • In our cohort of 105 paediatric patients with rheumatic diseases, the clinical course of COVID-19 was mild and 44% of cases were asymptomatic. Three cases required hospital admission with no complications. Seroprevalence was 20%. • No association was found between disease activity or treatment with corticosteroids and symptomatic or asymptomatic infection. Higher disease activity and treatment with oral corticosteroids appeared to be risk factors for laboratory-confirmed SARS-CoV-2 infection.

Keywords: COVID-19; Child; Glucocorticoids; Rheumatic diseases.

PubMed Disclaimer

References

    1. Sisk B, Cull W, Harris JM, Rothenburger A, Olson L 2020 National trends of cases of COVID-19 in children based on US State Health Department data. [cited 2021 Apr 27]; Available from10.1542/peds.2020-027425 - PubMed
    1. Hasseli R, Mueller-Ladner U, Schmeiser T, Hoyer BF, Krause A, Lorenz HM, et al. 2020 National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open [Internet]. [cited 2021 May 5];6(2). Available from: https://pubmed.ncbi.nlm.nih.gov/32878994/ - PMC - PubMed
    1. Xu C, Yi Z, Cai R, Chen R, Thong BYH, Mu R 2021 Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data [Internet]. Autoimmunity Reviews. Elsevier B.V. [cited 2021 Apr 27]. Available from 10.1016/j.autrev.2021.102778 - PMC - PubMed
    1. Gianfrancesco M, Hyrich KL, Hyrich KL, Al-Adely S, Al-Adely S, Carmona L, et al. 2020 Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis [Internet] [cited 2021 Apr 24];79(7):859–66. Available from: /pmc/articles/PMC7299648/ - PMC - PubMed
    1. Nuño L, Novella Navarro M, Bonilla G, Franco-Gómez K, Aguado P, Peiteado D, et al. 2020 Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases [Internet]. Vol. 79, Annals of the rheumatic diseases. BMJ Publishing Group; [cited 2021 May 3]. p. 1659–61. Available from: /pmc/articles/PMC7677491/ - PMC - PubMed